ABB Robotics has developed an automated neutralizing antibody testing system with the University of Texas Medical Branch (UTMB) to determine an individual’s immunity to various strains of COVID. Developed by ABB Robotics, Life Sciences, and Healthcare Lab, the company claims the system increases the number of neutralizing antibody tests performed from 15 to over 1,000 daily. Researchers at UTMB say the ability to carry out more daily tests is the key to generating more data on individual immunity profiles that will help control the further spread of the virus. The aim of the automated neutralizing antibody test is to specifically detect a SARS-CoV-2 neutralizing antibody without cross-reaction with other infections. The automated neutralizing antibody test was developed using the RobotStudio® offline programming software to model, iterate, and test different combinations of lab equipment and robot positions.